When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PIRS - FDA suspends enrollment in Pieris' early-stage study of lead drug
Pieris Pharmaceuticals Inc.
The FDA has instituted a partial clinical hold on Phase 1 clinical trials of Pieris Pharmaceuticals' (NASDAQ:PIRS) lead candidate PRS-343 until the company conducts an additional in-use and compatibility study with various infusion materials under specific conditions aimed at confirming the suitability of the PRS-343 for administration in clinical settings.
More news on: Pieris Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,